Business Context and Reporting Period
This Form 8-K Current Report was filed by Bristol-Myers Squibb Company on March 6, 2009, covering events that occurred on March 3, 2009. The filing addresses corporate governance changes, specifically the appointment of a new President and Chief Operating Officer and the election of a new Board member.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial statement data.
Material Changes
- Executive Appointment: Lamberto Andreotti was appointed as President and Chief Operating Officer.
- Board Election: Mr. Andreotti was elected as a member of the Board of Directors, increasing the Board size to eleven members.
- Independence Status: Due to his employment, Mr. Andreotti is not considered independent under NYSE Listing Standards or the Board's independence standards.
Outlook, Risks, and Management Commentary
Compensation: Mr. Andreotti will receive compensation for his executive role under the company's standard program but will not be compensated for his service as a director. There are no related-party transactions between the company and Mr. Andreotti.
Future Events: Mr. Andreotti will stand for election by stockholders at the Annual Meeting on May 5, 2009.
Background: Mr. Andreotti is 58 years old, has worked for the company for 11 years, and previously served as Executive Vice President and Chief Operating Officer since May 2007.
Investor Verification Checklist
- Verify the press release (Exhibit 99.1) for additional details on the leadership transition.
- Confirm the date of the Annual Meeting of Stockholders (May 5, 2009) for the director election.
- Review the company's standard executive compensation program to understand the financial implications of the new appointment.
- Check subsequent filings for any changes to the Board's independence composition.